A Retrospective Study to Validate BioEP as an Assessment Aid for Seizure Susceptibility

NCT ID: NCT06669364

Last Updated: 2024-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-01

Study Completion Date

2025-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this retrospective study is to validate BioEP during routine adult EEG recording in an outpatient setting, using patients with a known epilepsy diagnosis. The main objectives of the study are:

* To validate BioEP during routine adult EEG recording in an outpatient setting, using patients with a known diagnosis
* To examine whether the use of BioEP could support a more efficient patient pathway to diagnosis (thus adding economic value), by reducing time to final diagnosis and/or the number of clinical appointments needed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epilepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Epilepsy

Device: BioEP

All patient's EEG will have the BioEP score conducted on it

No interventions assigned to this group

Non-epilepsy

Device: BioEP

All patient's EEG will have the BioEP score conducted on it

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults (age 22 and above) who had a routine EEG in an outpatient setting, following a suspected seizure.
* A diagnosis of epilepsy or alternate condition has been reached. A period of at least 3 years has passed since ultimate diagnosis, which itself has remained stable.
* EEGs performed to ABRET \& IFCN standards using a minimum of 19 electrodes and additional technical requirements.

Exclusion Criteria

* Subject was not suspected of having had a seizure or epilepsy.
* Subject has a dual diagnosis of epilepsy AND non-epileptic seizures.
* Subject's final diagnosis unknown, unstable, or less than three years passed since an unchanged diagnosis was made.
* Incomplete or unreliable metadata, such as the age, sex, and treatment status at the time of the EEG recording.
* Sleep deprived EEG recordings in the outpatient setting.
* Encephalopathic subjects.
* Poor quality EEGs (multiple artefacts) that do not fulfil technical criteria for analysis.
* Known structural abnormalities or skull breaches, including historical cases, or with people with metal or plastic implants in their brain or skull.
Minimum Eligible Age

22 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Neuronostics Ltd

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Milaana Mainstone

Role: STUDY_DIRECTOR

Neuronostics Ltd

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Milaana Mainstone

Role: CONTACT

+44 (0)117 457 2292

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NNBioEP003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Localizing Epileptic Networks Using MRI and iEEG
NCT04649008 RECRUITING EARLY_PHASE1
ECV - Epihunter Clinical Validation
NCT04615442 COMPLETED NA
Human Intracranial Electrophysiology
NCT05529264 RECRUITING NA
Earbud EEG Feasibility Study
NCT05257811 COMPLETED